Daixing Zhong

956 total citations
25 papers, 476 citations indexed

About

Daixing Zhong is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daixing Zhong has authored 25 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daixing Zhong's work include Ubiquitin and proteasome pathways (3 papers), Cancer-related molecular mechanisms research (3 papers) and Immune Response and Inflammation (3 papers). Daixing Zhong is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Cancer-related molecular mechanisms research (3 papers) and Immune Response and Inflammation (3 papers). Daixing Zhong collaborates with scholars based in China and Germany. Daixing Zhong's co-authors include Zhenqi Ding, Wenliang Zhai, Xiaolong Yan, Xiaofei Li, Jinbo Zhao, Lijun Huang, Xinyu Wu, Jin Wu, Jin Wu and Xinyu Wu and has published in prestigious journals such as PLoS ONE, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Daixing Zhong

23 papers receiving 464 citations

Peers

Daixing Zhong
Yulin Luo China
Zoi Kanaki Greece
Xin Jiao China
Kun Yu China
Daixing Zhong
Citations per year, relative to Daixing Zhong Daixing Zhong (= 1×) peers Zhimin Yang

Countries citing papers authored by Daixing Zhong

Since Specialization
Citations

This map shows the geographic impact of Daixing Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daixing Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daixing Zhong more than expected).

Fields of papers citing papers by Daixing Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daixing Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daixing Zhong. The network helps show where Daixing Zhong may publish in the future.

Co-authorship network of co-authors of Daixing Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Daixing Zhong. A scholar is included among the top collaborators of Daixing Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daixing Zhong. Daixing Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Daixing, et al.. (2024). H2O2-activated NIR fluorescent probe with tumor targeting for cell imaging and fluorescent-guided surgery. Sensors and Actuators B Chemical. 418. 136249–136249. 10 indexed citations
2.
Lan, Ke, Xiaolong Yan, Jie Lei, et al.. (2024). Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study. International Journal of Surgery. 111(1). 1547–1551.
3.
Jiang, Wenjie, et al.. (2024). Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures. International Journal of Clinical Oncology. 30(2). 277–297.
4.
Tian, Feng, Jie Lei, Yunfeng Ni, et al.. (2022). Regulation of CD18 stability by SIGIRR ‐modulated ubiquitination: new insights into the relationship between innate immune response and acute lung injury. FEBS Journal. 290(10). 2721–2743. 3 indexed citations
5.
Zhong, Daixing, et al.. (2022). Knowledge management of product design: A requirements-oriented knowledge management framework based on Kansei engineering and knowledge map. Advanced Engineering Informatics. 52. 101541–101541. 30 indexed citations
6.
Zhong, Daixing, et al.. (2022). A hybrid approach based on rough-AHP for evaluation in-flight service quality. Multimedia Tools and Applications. 81(21). 30797–30819. 1 indexed citations
7.
Tian, Feng, Qiang Lu, Jie Lei, et al.. (2020). Negative Effects of SIGIRR on TRAF6 Ubiquitination in Acute Lung Injury In Vitro. Journal of Immunology Research. 2020(1). 5097920–5097920. 6 indexed citations
8.
Wang, Lei, Ting Guo, Hao Zhang, et al.. (2019). Rare paraneoplastic erythroderma associated with ectopic neuron-specific enolase deposition in basal cells. Annals of Translational Medicine. 7(3). 51–51. 2 indexed citations
9.
Wang, Lei, Lijun Huang, Xiaofei Li, et al.. (2018). Three-Dimensional Printing PEEK Implant: A Novel Choice for the Reconstruction of Chest Wall Defect. The Annals of Thoracic Surgery. 107(3). 921–928. 55 indexed citations
10.
Ru, Yi, Qinhao Wang, Xiping Liu, et al.. (2016). The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL. Scientific Reports. 6(1). 28352–28352. 20 indexed citations
11.
Huang, Lijun, Lei Wang, Jiankang He, et al.. (2016). Tracheal suspension by using 3-dimensional printed personalized scaffold in a patient with tracheomalacia. Journal of Thoracic Disease. 8(11). 3323–3328. 48 indexed citations
12.
Tian, Feng, Yong Chol Han, Jian Song, et al.. (2016). Pulmonary resident neutrophils regulate the production of GMCSF and alveolar macrophages. FEBS Journal. 283(8). 1465–1474. 12 indexed citations
13.
Zhong, Daixing, Yi Ru, Qinhao Wang, et al.. (2015). Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling. Cancer Letters. 359(1). 57–64. 11 indexed citations
14.
Lei, Jie, Wenhai Li, Ye Yang, et al.. (2014). TC-1 Overexpression Promotes Cell Proliferation in Human Non-Small Cell Lung Cancer that Can Be Inhibited by PD173074. PLoS ONE. 9(6). e100075–e100075. 11 indexed citations
15.
Wang, Lei, Ting Guo, Qiang Lü, et al.. (2014). Sea-Urchin-Like Au Nanocluster with Surface-Enhanced Raman Scattering in Detecting Epidermal Growth Factor Receptor (EGFR) Mutation Status of Malignant Pleural Effusion. ACS Applied Materials & Interfaces. 7(1). 359–369. 38 indexed citations
16.
Wu, Xinyu, Daixing Zhong, Quan Q. Gao, et al.. (2013). MicroRNA-34a Inhibits Human Osteosarcoma Proliferation by Downregulating Ether à go-go 1 Expression. International Journal of Medical Sciences. 10(6). 676–682. 64 indexed citations
17.
Yu, Haitao, Yunfeng Ni, Xiaofei Li, et al.. (2012). Shikonin attenuates lipopolysaccharide-induced acute lung injury in mice. Journal of Surgical Research. 182(2). 303–311. 35 indexed citations
18.
Wu, Xinyu, Daixing Zhong, Bin Lin, et al.. (2012). p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells. Radiology and Oncology. 47(1). 42–49. 21 indexed citations
19.
Wu, Jin, Xinyu Wu, Daixing Zhong, et al.. (2012). Short Hairpin RNA (shRNA) Ether à go-go 1 (Eag1) Inhibition of Human Osteosarcoma Angiogenesis via VEGF/PI3K/AKT Signaling. International Journal of Molecular Sciences. 13(10). 12573–12583. 30 indexed citations
20.
Zhao, Jinbo, et al.. (2010). Intraoperative recurrent laryngeal nerve monitoring during surgery for left lung cancer. Journal of Thoracic and Cardiovascular Surgery. 140(3). 578–582. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026